Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
429 Leser
Artikel bewerten:
(1)

Daily Mail and General Trust plc: Rule 8.4 Disclosure

DJ Rule 8.4 Disclosure

Daily Mail and General Trust plc (DMGT) Rule 8.4 Disclosure 10-Nov-2021 / 09:56 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:                       Vyvyan Harmsworth 
(b) Owner or controller of interests and short positions disclosed, if 
different from 1(a): 
                                     N/A 
 The naming of nominee or vehicle companies is insufficient. For a 
trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities 
this form relates:                            Daily Mail and General Trust plc 
 Use a separate form for each offeror/offeree 
(d) Status of person making the disclosure:               Person acting in concert with Rothermere 
                                     Continuation Limited ("RCL"), the offeror 
 e.g. offeror, offeree, person acting in concert with the offeror/ 
offeree (specify name of offeror/offeree) 
(e) Date dealing undertaken:                       9 November 2021 
(f) In addition to the company in 1(c) above, is the discloser making 
disclosures in respect of any other party to the offer?         N/A 
 If it is a cash offer or possible cash offer, state "N/A" 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Class of relevant security: 
 
 
                                          Interests Short positions 
                                          Number % Number    % 
(1) Relevant securities owned and/or controlled:                  -   - -       - 
(2) Cash-settled derivatives: 
                                          -   - -       - 
 
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: -   - -       - 
 
                                          -   - -       - 
 TOTAL: 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists: None 
Details, including nature of the rights concerned and relevant percentages: N/A 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1 (c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

Purchase/sale 
Class of relevant security        Number of securities Price per unit 
 
              Sale 
A Ordinary Shares            450         1131.0504p 
 

The Takeover Panel Executive has confirmed that this sale has been made free from any consequences under the Takeover Code.

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

Purchases/ 
Class of relevant   sales     Total number of    Highest price per unit paid/  Lowest price per unit paid/ 
security               securities       received            received 
 
            - 
-                  -           -               - 
 

(b) Cash-settled derivative transactions

Product    Nature of dealing 
Class of relevant description                              Number of reference Price per 
security            e.g. opening/closing a long/short position, increasing/ securities      unit 
         e.g. CFD   reducing a long/short position 
         - 
-                -                            -          - 
 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Type 
Class of   Product     Writing,      Number of securities Exercise            Option money 
relevant   description e.g. purchasing,     to which option   price per e.g.     Expiry paid/ received 
security   call option   selling, varying  relates       unit    American,  date  per unit 
                etc.                        European 
                                          etc. 
-       -        -          -          -     -      -   - 

(ii) Exercise

Class of relevant     Product description Exercising/ exercised 
security                   against           Number of securities Exercise price per unit 
             e.g. call option 
                                                - 
-             -          -              - 
 

(d) Other dealings (including subscribing for new securities)

Nature of dealing 
Class of relevant security                Details Price per unit (if applicable) 
              e.g. subscription, conversion 
              - 
-                            -    - 
 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to 
relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer 
or person acting in concert making the disclosure and any other person: 
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or 
understandings, state "none" 
 
None 
 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person 
acting in concert making the disclosure and any other person relating to: 
(i) the voting rights of any relevant securities under any option; or 
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is 
referenced: 
If there are no such agreements, arrangements or understandings, state "none" 
 
None 
 

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) NO 
Supplemental Form 8 (SBL)       NO 
Date of disclosure: 10 November 2021 
Contact name:    Áine O'Reilly 
          Director of RCL 
Telephone number:  +44 (0) 1534 870864 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00BJQZC279 
Category Code: FEE - Daily Mail and General Trust plc 
TIDM:      DMGT 
LEI Code:    4OFD47D73QFJ1T1MOF29 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:  126491 
EQS News ID:  1247812 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1247812&application_name=news

(END) Dow Jones Newswires

November 10, 2021 04:56 ET (09:56 GMT)

© 2021 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.